{"entity":{"type":"insider","cik":"0001848319","url":"/insider/0001848319","json_url":"/insider/0001848319.json","name":"SR One Capital Fund I Aggregator LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":5,"first":"2021-04-01","last":"2023-11-29","span_basis":"filed_date"},"name_variants":[{"name":"SR One Capital Fund I Aggregator LP","source":"filing","n_filings":5,"first_seen":"2021-04-01","last_seen":"2023-11-29"}],"transactions":[{"id":7817040,"accession":"0001209191-23-056920","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-056920","line_url":"/filing/0001209191-23-056920","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"eFFECTOR Therapeutics, Inc.","issuer_ticker":"EFTR","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest I, LLC; SR One Co-Invest I Manager, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":609163.0,"shares_display":"609,163","price_per_share":0.6065,"price_display":"0.61","price_state":"stated","total_value":369457.3595,"total_display":"369,457.36","total_whole":"369,457","shares_owned_after":4391536.0,"shares_owned_after_display":"4,391,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-29","scope":"insider","n_lines":2},{"id":7897826,"accession":"0001209191-23-029610","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-23-029610","line_url":"/filing/0001209191-23-029610","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"SR One Co-Invest II Manager, LLC; George Simeon; SR One Capital Fund I Aggregator LP; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest II, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"SR One Co-Invest II Manager, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1012833.0,"shares_display":"1,012,833","price_per_share":45.01168242938372,"price_display":"45.01","price_state":"stated","total_value":45589317.35,"total_display":"45,589,317.35","total_whole":"45,589,317","shares_owned_after":2834879.0,"shares_owned_after_display":"2,834,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-05-11","filed_date":"2023-05-15","scope":"insider","n_lines":4},{"id":6658980,"accession":"0001209191-22-062226","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-062226","line_url":"/filing/0001209191-22-062226#line-3","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":null,"owner_name":"SR ONE CAPITAL PARTNERS I, LP; SR ONE CAPITAL MANAGEMENT, LLC; SR One Capital Fund I Aggregator LP","owner_display_name":"SR ONE CAPITAL PARTNERS I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":8.1358,"price_display":"8.14","price_state":"stated","total_value":325432.0,"total_display":"325,432.00","total_whole":"325,432","shares_owned_after":6526476.0,"shares_owned_after_display":"6,526,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-20","scope":"insider"},{"id":6658978,"accession":"0001209191-22-062226","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-062226","line_url":"/filing/0001209191-22-062226#line-2","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":null,"owner_name":"SR ONE CAPITAL PARTNERS I, LP; SR ONE CAPITAL MANAGEMENT, LLC; SR One Capital Fund I Aggregator LP","owner_display_name":"SR ONE CAPITAL PARTNERS I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":360000.0,"shares_display":"360,000","price_per_share":8.6336,"price_display":"8.63","price_state":"stated","total_value":3108096.0,"total_display":"3,108,096.00","total_whole":"3,108,096","shares_owned_after":6486476.0,"shares_owned_after_display":"6,486,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-20","scope":"insider"},{"id":6658974,"accession":"0001209191-22-062226","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-062226","line_url":"/filing/0001209191-22-062226#line-1","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":null,"owner_name":"SR ONE CAPITAL PARTNERS I, LP; SR ONE CAPITAL MANAGEMENT, LLC; SR One Capital Fund I Aggregator LP","owner_display_name":"SR ONE CAPITAL PARTNERS I, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":8.2811,"price_display":"8.28","price_state":"stated","total_value":4140550.0,"total_display":"4,140,550.00","total_whole":"4,140,550","shares_owned_after":6126476.0,"shares_owned_after_display":"6,126,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2022-12-20","scope":"insider"},{"id":6693285,"accession":"0001209191-22-008281","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-22-008281","line_url":"/filing/0001209191-22-008281","is_derivative":false,"issuer_cik":"0001595117","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001595117","owner_cik":null,"owner_name":"George Simeon; SR One Capital Fund I Aggregator LP; SR One Co-Invest II Manager, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Co-Invest II, LLC; SR ONE CAPITAL MANAGEMENT, LLC","owner_display_name":"George Simeon","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666667.0,"shares_display":"1,666,667","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":25000005.0,"total_display":"25,000,005.00","total_whole":"25,000,005","shares_owned_after":2033196.0,"shares_owned_after_display":"2,033,196","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-10","scope":"insider","n_lines":2},{"id":4727496,"accession":"0001209191-21-024238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-024238","line_url":"/filing/0001209191-21-024238#line-3","is_derivative":false,"issuer_cik":"0001807120","issuer_name":"Design Therapeutics, Inc.","issuer_ticker":"DSGN","issuer_name_source":null,"issuer_url":"/issuer/0001807120","owner_cik":null,"owner_name":"SR ONE CAPITAL MANAGEMENT, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Capital Fund I Aggregator LP","owner_display_name":"SR ONE CAPITAL MANAGEMENT, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":5626476.0,"shares_owned_after_display":"5,626,476","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-30","filed_date":"2021-04-01","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001828522","name":"eFFECTOR Therapeutics, Inc.","url":"/issuer/0001828522","role":"Ten percent owner","n_filings":1,"first_seen":"2023-11-29","last_seen":"2023-11-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Ten percent owner","n_filings":2,"first_seen":"2022-02-10","last_seen":"2023-05-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001807120","name":"Design Therapeutics, Inc.","url":"/issuer/0001807120","role":"Ten percent owner","n_filings":2,"first_seen":"2021-04-01","last_seen":"2022-12-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001848319","retrieved_at":"2026-08-23T07:04:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}